Gender-Affirming Care: What Patients Report

The main article evaluates gender-affirming care using systematic reviews, RCTs, and cohort studies. These measure whether interventions produce statistically detectable changes in clinical outcomes. But some effects of medical care are only visible from the patient’s perspective: how a treatment affects daily life, sense of self, relationships, and wellbeing in ways that standardized depression or anxiety scales don’t fully capture.

Patient-reported outcomes are not anecdotes substituting for evidence. They are a distinct and recognized form of evidence studied through validated instruments and qualitative research methodology. A 2023 systematic review of patient-reported outcome measures in gender-affirming care identified 286 studies using such measures but found significant inconsistency in implementation, suggesting the field has not yet built the infrastructure to capture patient experience systematically.

Patient-reported outcomes from published qualitative studies are subject to selection effects (care-seeking samples skew positive), recall bias, and survivorship bias. They cannot establish population-level causal claims. Negative experiences are underrepresented in the published qualitative literature because many people who had bad outcomes don’t return to providers who didn’t help them. This page should not be read as representative of all possible outcomes. It presents documented experiences from published research, not a random sample.

Sansfaçon et al. (2019, Canada) interviewed 35 trans and gender-diverse youth ages 9–17 across gender-affirming specialty clinics. Youth described puberty blockers as stopping constant worry about unwanted bodily changes. Those on hormones described improvements in comfort and wellbeing. None reported regret at the time of interview. Limitation: care-seeking sample from specialty clinics; positive selection likely.

Riggs et al. (2020, Australia) conducted interviews with transgender youth ages 11–17 and their parents. The study’s title comes directly from a participant’s words about what family support meant to them. Youth and families consistently described timely access to care as reducing acute distress. Limitation: qualitative, small sample, families engaged with care.

Carlile et al. (2023, England) found that youth described blockers as creating psychological space — pausing unwanted changes while allowing time to think. Those on testosterone described increased physical comfort. Delays and denials of care were described as causing significant distress, including worsening mental health during waiting periods. Limitation: qualitative, care-seeking, UK context with long wait times.

Christiano et al. (2024) documented experiences after top surgery. Participants reported reduced anxiety in public spaces, less dysphoria, and greater self-recognition. Limitation: qualitative, care-seeking, surgical sample (higher commitment threshold).

Olson et al. (2022, 5-year follow-up) found 94% of socially transitioned youth still identified as trans after 5 years, 3.5% identified as nonbinary, and 2.5% identified as cisgender. While quantitative, this is a patient-trajectory study that reflects real-world persistence. Limitation: socially transitioned sample (already committed to transition at baseline); not generalizable to all gender-questioning youth.

Across these qualitative studies, patients consistently surface outcomes the quantitative literature underweights: fear in public spaces, the psychological burden of hiding, the experience of waiting for care, and the difference between being tolerated and being supported. The most common theme is not “hormones cured my depression” but “I can exist in the world more comfortably.”

Vandenbussche (2021) surveyed 237 self-identified detransitioners. 70% reported that mental health conditions contributed to their initial gender identification. 55% said they did not receive adequate evaluation before beginning transition. High rates of depression (70%), anxiety (63%), PTSD (33%), ADHD (24%), and autism (20%) were documented. Limitation: self-selected online sample; recruited partly through detransitioner communities; no comparison group; causal direction of mental health conditions unclear (may have preceded, resulted from, or been independent of transition).

Littman (2021) surveyed 100 detransitioners. Common themes included feeling that medical providers had not explored alternative explanations for distress, discovering their dysphoria had other sources (trauma, internalized homophobia, autism-related identity confusion), and experiencing difficulty accessing support for detransition. Many reported feeling abandoned by the same clinical system that had facilitated their transition. Limitation: convenience sample; recruited online; not representative of all detransitioners.

USTS data (2015, n=27,715). Among the 8–13% who had ever detransitioned, 82.5% cited at least one external factor: pressure from a parent (36%), too much harassment or discrimination (31%), difficulty getting a job (29%). 68% of those who detransitioned for external reasons later re-transitioned when circumstances improved. For the remainder, reasons included evolving identity, health concerns, and discovery that dysphoria had other sources. Limitation: survey of trans-identified adults; underrepresents those who fully disidentified from the trans community.

MacKinnon et al. (2024) found 16.8% of youth discontinued medical care, but only 4.1% identified as detransitioning. Most who stopped remained trans or nonbinary and discontinued for other reasons (access, side effects, achieving desired changes). Limitation: clinical sample; may undercount those who left care entirely.

Across published detransitioner research, the most consistent theme is not “transition was wrong for everyone” but rather “my specific situation needed more careful assessment.” Many describe pre-existing conditions (trauma, autism, depression, internalized homophobia) that were not adequately explored. Many describe a healthcare system that was better at initiating transition than at supporting those who needed to stop. The experience of being unable to find clinical support for detransition is nearly universal in the qualitative literature.

A smaller but significant subgroup describes genuinely regretting physical changes — particularly voice changes from testosterone and surgical outcomes. These reports are real and should not be minimized. They represent a minority of transition outcomes, but for the individuals involved, the consequences are serious and often irreversible.

Both the positive and negative experiences described above are real. The question readers are likely asking is: how common is each? The rate data from the main article provides context.

The strong majority of people who receive gender-affirming care report positive outcomes and continue to identify as transgender. Surgical regret is rare (~1%). Persistence after social transition is very high (94%+). The majority of those who detransition do so because of external pressures rather than changed identity, and most re-transition when safe.

At the same time, a meaningful minority — somewhere between 2% and 13% depending on the measure and population — does detransition, discontinue, or experience outcomes they did not want. Some have comorbidities that were not adequately assessed. Some discover their dysphoria had other sources. Some experience irreversible physical changes they regret. These are not negligible numbers, and the individuals involved deserve better clinical infrastructure than currently exists.

Both realities are true simultaneously. A treatment can help the large majority while also failing a meaningful minority. Honest policy must account for both.